Borealis Foods Inc. logo

Borealis Foods Inc.(BRLS)

upturn advisory logo
EXPLORE ADVISORIES AND THEIR HISTORY
QUALITY SIGNAL
1-STAR RATING
PASS
LAST CLOSE
$0.96
11/13/2026
(24-hour delay)

Advisory History & Simulated Performance *

*as per simulation (see disclosures)
  • ALL
  • 1Y
  • 1M
  • 1W
  • BUY Advisory
  • SELL Advisory (Profit)
  • SELL Advisory (Loss)
  • Profit
  • Loss
  • PASS (Skip)
Upturn Stock price based on last close iconStock price based on last close
Simulated performance—not actual client returns. Excludes advisory subscription fees, trading commissions, and taxes, which would reduce returns. Results depend on calculation assumptions and do not guarantee future outcomes. See Disclosures for full methodology, assumptions, and limitations.

Advisory Performance History (Simulated)Advisory Performance History info

Simulated performance—not actual client returns. Excludes advisory subscription fees, trading commissions, and taxes, which would reduce returns. Results depend on calculation assumptions and do not guarantee future outcomes. See Disclosures for full methodology, assumptions, and limitations.

Upturn Advisory & Investor View for BRLS

11/13/2026: BRLS (1-star) is currently NOT-A-BUY. Pass it for now.

Borealis Foods Inc. is a micro-cap food manufacturing company specializing in plant-based, high-protein instant ramen products under brands like Chef Woo and Ramen Express. The company's primary operational strengths include its proprietary formulations and a rapidly expanding footprint in U.S. school foodservice channels. Its main investment story centers on capturing market share in the health-conscious and budget-friendly convenient food sector. However, the company faces notable financial risks, including persistent net losses, working capital deficits, and intense competition from global food conglomerates. BRLS represents a high-risk growth opportunity best suited for speculative or momentum-oriented investors willing to monitor ongoing liquidity management and distribution milestones.

How to Read the Upturn Advisory

The Upturn Star Rating and the current BUY, SELL, or PASS advisory are generated by Upturn’s AI advisory engine based on proprietary signal analysis, price behavior, advisory history, and historical signal performance.

Company fundamentals, valuation, risks, and news provide supporting context about the business.

Investor Fit

Investor styleFitWhy
Growth investorMixed fitOffers top-line revenue expansion and innovative plant-based product lines, but must overcome near-term profitability hurdles.
Momentum investorStrong fit while signal remains positiveProne to sharp sentiment shifts and short-term price momentum driven by distribution milestones and institutional channel updates.
Value investorWeak fitUnprofitable earnings history and negative working capital make it unsuitable for traditional value metrics.
Dividend investorWeak fitThe company does not pay dividends and retains all capital for business growth.
Low-risk investorWeak fitHigh share price volatility and liquidity considerations create a high-risk profile for conservative investors.

Risk Profile

Risk factorLevelWhy it matters
Price volatilityHighMicro-cap status and low float lead to sharp intraday and periodic price swings.
Valuation riskMedium / highUncertainty surrounding long-term earnings potential complicates fundamental valuation models.
Competition risk (global food conglomerates)HighCompeting against heavily capitalized food giants limits pricing power and market share acquisition speed.
Business qualityMediumInnovative product lines show strong health positioning, but bottom-line net losses constrain overall franchise quality.
Dividend incomeLow / noneNo cash distribution is provided to shareholders.
Execution riskHighSuccessful scale-up relies heavily on executing manufacturing efficiencies and expanding institutional distribution smoothly.

Key Highlights

Company Size Small-Cap Stock
Market Capitalization 20.60M USD
Price to earnings Ratio -
1Y Target Price -
Price to earnings Ratio -
1Y Target Price -
Volume (30-day avg) 8.8K shares
Beta 0.45
52 Weeks Range 0.60 - 3.48
Updated Date 11/15/2026
52 Weeks Range 0.60 - 3.48
Updated Date 11/15/2026
Dividends yield (FY) -
Basic EPS (TTM) -0.85

Sector & Industry Intelligence

Sector

Consumer Defensive

Defensive
Sentiment
Correction Expected
Momentum
BUY Breadth Improving
BUY participation
95.0%
Active BUY / eligible
19 / 20
30-Day BUY Count Change
+13
Market state
Correction Expected

More qualifying stocks are receiving or maintaining BUY advisories, indicating improving market participation.

Industry

Industry classification is unavailable for this snapshot.

Sector signal summarizes BUY breadth conditions for the sector. It does not override this stock’s BUY, SELL, or PASS advisory.

Price Behavior

Steep Decline
PRICE PATH

Steep Decline

The stock price has dropped sharply with strong downward pressure.

Extreme Price Shocks
PRICE STABILITY

Extreme Price Shocks

The stock has experienced exceptionally large and disruptive price movements during the period.

Analysis of Past Performance

Type Stock
Historic Profit -84%
Avg. Invested days 15
Today’s Advisory PASS
Upturn Advisory Rating upturn star rating icon
Upturn Advisory Performance Upturn Advisory Performance icon 1.0
Stock Returns Performance Upturn Returns Performance icon 1.0
Upturn Profits based on simulation icon Profits based on simulation
Upturn last close icon Last Close 11/13/2026

Upturn Scorecard

Upturn Star Rating

★★★★★
BRLS receives a 2-star rating, reflecting soft or weak scores across the available pillars. The rating is constrained by weak unit economics, soft analyst coverage, and weak price momentum.

Company Fundamentals

★★★★★
BRLS has moderate overall fundamentals (3 stars), with soft financial health, moderate growth momentum, and moderate ownership. In FY2025 versus FY2024, solid earnings growth (+25.1%) is partially offset by weak cash generation (FCF margin -14.9%), negative revenue growth (-11.2%), weak profitability (net margin -42.5%).

Financial Health Rating

★★★★★
BRLS's financial health is soft, with the relatively strongest area being soft efficiency, including operating-expense and cost-of-revenue discipline (opex 65.2% of revenue). Overall financial-health metrics support a 2-star score.

Growth Momentum Score

★★★★★
Free-cash-flow growth is BRLS's strongest growth driver at +26.2% FY2025 versus FY2024 (solid, 4 stars). By comparison, earnings growth (+25.1%, solid) is also solid, while revenue growth (-11.2%, negative) holds the profile back, so recent growth is not broad-based across the business.

Ownership

★★★★★
Institutional ownership is 0.4% (soft) and 30.1% of outstanding shares are publicly tradable (moderate). Insider ownership of 45.51% supports management-shareholder alignment.

Top 5 Institutional Investors

UBS Group AG 0.16%
XTX Topco Ltd 0.09%
Caitong International Asset Management Co., Limited. 0.00%
Morgan Stanley - Brokerage Accounts 0.00%
TWO SIGMA SECURITIES, LLC 0.00%

Unit Economics (Per $1K Revenue)

★★★★★
BRLS generates approximately $405 of gross profit, $-247 of operating income, and $-149 of free cash flow for every $1,000 of revenue. Based on FY2025 results. Operating losses and cash burn explain the 1-star rating, with weak cash conversion and weak capital efficiency.

Economic Dimensions

★★★★★
Effective Tax Rate: 60.58%

Quantitative Style Profile

★★★★★
BRLS has a relatively low-volatility profile. Weak momentum is the primary drawback.

Style Classification

Quality Focused

Value-OrientedLow VolatilitySmall / Mid Cap Risk

How Company Makes Money

Business areaWhat it includesRetail investor read
Retail Packaged FoodsSales of Chef Woo, Ramen Express, and Woodles ramen products through supermarkets, club stores, and e-commerce platforms.This is the primary consumer-facing engine driving brand visibility and recurring retail grocery revenue.
Institutional FoodserviceBulk sales of nutritional noodle products to school districts and institutional cafeterias across North America.This segment provides high-volume, dependable institutional contracts that have shown rapid year-over-year expansion.

Valuation

Trailing PE -
Forward PE -
Enterprise Value 47.62M
Price to Sales(TTM) 0.67
Enterprise Value 47.62M
Price to Sales(TTM) 0.67
Enterprise Value to Revenue 1.58
Enterprise Value to EBITDA -
Shares Outstanding 21.46M
Shares Floating 6.47M
Shares Outstanding 21.46M
Shares Floating 6.47M
Percent Insiders 45.51
Percent Institutions 0.36

Financial Metrics

🧭 Investment Snapshot

Total Revenue (Scale)

Information icon Total money earned from selling products or services before any costs. It is needed to understand the scale of the business and its ability to generate income.

Net Income (Profit)

Information icon Final profit after all expenses, interest, and taxes are deducted. It is needed to determine the overall profitability available to shareholders.

Free Cash Flow (Cash Strength)

Information icon Cash remaining after operating activities and capital expenditures, showing cash available for growth. It is needed to evaluate the company’s ability to invest, pay dividends, or reduce debt.

📈 Growth & Strength

Operating Income (Core Profit)

Information icon Profit from core operations after deducting all operating expenses. It is needed to measure how efficiently the company runs its primary business activities.

EBITDA (Cash Earnings)

Information icon Earnings before interest, taxes, depreciation, and amortization, indicating operating cash potential. It is needed to compare operating performance across companies without accounting or financing differences.

Gross Profit (Unit Profitability)

Information icon Revenue minus cost of revenue, showing profit after direct production costs. It is needed to evaluate core business profitability before overhead expenses.

🛡️ Financial Safety

Cash (Liquidity Buffer)

Information icon Total cash and cash equivalents on hand. It is needed to evaluate immediate liquidity and financial flexibility.

Total Debt (Leverage Risk)

Information icon Total debt including both short-term and long-term components. It is needed to assess the company’s leverage and financial risk.

Net Working Capital (Short-Term Health)

Information icon Current assets minus current liabilities, indicating short-term liquidity strength. It is needed to assess whether the company can meet its short-term obligations.

🧱 Balance Sheet Strength

Stockholder Equity (Net Worth)

Information icon Total equity value held by shareholders. It is needed to understand the net worth of the company from the owners’ perspective.

Total Assets (Asset Base)

Information icon The full value of everything the company owns, including cash, inventory, equipment, and investments. It is needed to understand the resource base used to generate revenue.

Income Before Tax (Pre-Tax Earnings)

Information icon Income before provision for income taxes. It is needed to analyze profitability independent of tax structures.

⚙️ Cost & Drag Factors

Cost of Revenue (Production Cost)

Information icon Direct costs required to produce and deliver the products or services sold. It is needed to assess efficiency in production and service delivery.

Total Operating Expenses (Operating Cost)

Information icon Indirect costs of running the business such as salaries, marketing, and administration. It is needed to understand how much it costs to sustain ongoing business operations.

Income Tax Expense (Tax Drag)

Information icon Amount of taxes paid or payable to the government. It is needed to evaluate the impact of taxation on overall profitability.

Form CRS provides a relationship summary of our automated advisory services, flat subscription fees, and conflicts of interest. Form ADV Part 2A brochure contains complete details on services, billing, and disclosures. If any summary differs from our current regulatory filings, the filed Form ADV controls.